AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study NCT05992233 — intervention group
Intervention type: DEVICE
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: Only red light applied.
Study NCT06187181 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: implant overdenture
Description: . Videofluoroscopy swallowing evaluation was done using 10 ml of thin liquid bolus at three different oral conditions: Without dentures (WOD), with the conventional complete denture (CDs) and with mandibular implant retained overdenture (IODs).
Study NCT06187181 — intervention group
Intervention type: RADIATION
Group type: PLACEBO_COMPARATOR
Intervention: videofluroscopy
Description: videofluroscopy evaluation of swallowing function
Study NCT06187181 — intervention group
Intervention type: RADIATION
Group type: ACTIVE_COMPARATOR
Intervention: videofluroscopy
Description: videofluroscopy evaluation of swallowing function
Study NCT06336044 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Karisma
Description: Intradermal injection
Study NCT04939103 — intervention group
Intervention type: DEVICE
Intervention: TRUS-FNA
Description: Transrectal Ultrasound Guided Fine Needle Aspiration for rectal tumor
Study NCT06319274 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Iloprost
Description: Continuously infusion for 72 hours at 3 ml/hours. Treatment dose 1 ng/kg/min
Study NCT06319274 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Isotonic saline
Description: Continuously infusion for 72 hours at 3 ml/hours
Study NCT05791318 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Placebo
Description: Matching Placebo
Study NCT04964921 — intervention group
Intervention type: OTHER
Intervention: Device: ANSiScope Plus
Description: Heart rate variability measurement and vital signs monitoring will be performed on all subjects.
Study NCT05144295 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Lubiprostone Pill
Description: Oral pills for constipation (Lubiprostone) will be given in a dose range from 24 mcg once daily to 24 mcg twice daily according to the participant weight.
Study NCT05144295 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Lactulose Oral Liquid Product
Description: Lactulose  Lactulose, or Duphalac syrup at a dose of 1 ml/kg once or twice daily (maximum 60 mL/day)
Study NCT05144295 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Bisacodyl 5 MG
Description: Bisacodyl tablet (5 mg/tablet) in a dose of 2 tab/day for \< 12 years or 3 tab/day for > 12 years
Study NCT05144295 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Sodium Picosulfate
Description: Sodium Picosulfate 0.75% drops in a daily dose of 2.5-20 mg/day
Study NCT05967234 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Telehealth solution
Description: Telehealth solution offered for breastfeeding education.
Study NCT04686734 — intervention group
Intervention type: OTHER
Intervention: No active intervention (observational only)
Description: No active intervention (observational only)
Study NCT05642130 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: exersice program (Muscle energy technique)
Description: Post isometric relaxation for upper trapezius and sternocleidomastoid muscles. the therapist moved the subject's head into the position that put each muscle in stretch, once resistance/ barrier was felt, that position was held and subjects were asked to isometrically contract the target muscle with 20% of maximal contraction for 5 sec against mild resistance from the therapist, relax for 5 sec followed by passive stretch until reaching a new barrier for 30 sec, 3 repetitions for each muscle, 3sessions /week over a period of 4 weeks, In addition to the program designed for control group
Study NCT05642130 — intervention group
Intervention type: OTHER
Group type: SHAM_COMPARATOR
Intervention: exersice program (stretching and strengthening exercises ) In addition to postural advices
Description: static stretching exercise for upper trapezius and sternocleidomastoid . Repetitions: 3times/day, 3days/week over a period of 4 weeks, in addition to strengthening exercises of deep cervical flexors and scapular retractor muscles, 3sets of 12 repetitions with 6 sec hold. In addition to postural advices
Study NCT05642130 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: exersice program (stretching and strengthening exercises ) In addition to postural advices
Description: static stretching exercise for upper trapezius and sternocleidomastoid . Repetitions: 3times/day, 3days/week over a period of 4 weeks, in addition to strengthening exercises of deep cervical flexors and scapular retractor muscles, 3sets of 12 repetitions with 6 sec hold. In addition to postural advices
Study NCT04572854 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Pegcetacoplan
Description: Complement (C3) Inhibitor
Study NCT05525975 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Educational materials
Description: Educational materials will be developed by our interdisciplinary research team. Will consist of a brochure and a video. Both materials highlight important information about opioid medications, explain proper disposal of excess of opioid medications and provide drug-free pain management tools for postoperative pain.
Study NCT04572854 — intervention group
Intervention type: DRUG
Group type: OTHER
Intervention: Pegcetacoplan
Description: Complement (C3) Inhibitor
Study NCT04915339 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Physical activity
Description: The intervention is administrated through a computerized application as prescribed exercises (cognitive or physical). The specific measures that will be used to determine the effect of the intervention are psychological variables (mood, anxiety, well-being, cognitive variables...) and physical ones (Heart rate variability, stress biomarkers, fat and muscle mass, blood circulation...).
Study NCT05812755 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Vericiguat
Description: Vericiguat 10 mg administered orally starting 2 days prior to heart surgery through the day of surgery
Study NCT05812755 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: Matched placebo administered orally starting 2 days prior to heart surgery through the day of surgery
Study NCT04915339 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: cognitive training
Description: The intervention is administrated through a computerized application as prescribed exercises (cognitive or physical). The specific measures that will be used to determine the effect of the intervention are psychological variables (mood, anxiety, well-being, cognitive variables...) and physical ones (Heart rate variability, stress biomarkers, fat and muscle mass, blood circulation...).
Study NCT05168592 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Threat conditioning
Description: Day 1: The participant is repeatedly shown two stimulus (CS+,CS-), one at a time. CS+ is paired with an electric shock. CS- acts as a control stimulus. The stimuli consist of photos of two different objects. Stimuli will be counterbalanced between participants.
Study NCT05168592 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Imaginal extinction
Description: Day 1: Participants are repeatedly instructed to produce mental imagery of the two stimuli used during threat conditioning. Imagery is prompted through different written instructions presented in pseudo-randomized order on a screen. No shocks will be delivered.
Study NCT04915339 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: combined physical and cognitive training
Description: The intervention is administrated through a computerized application as prescribed exercises (cognitive or physical). The specific measures that will be used to determine the effect of the intervention are psychological variables (mood, anxiety, well-being, cognitive variables...) and physical ones (Heart rate variability, stress biomarkers, fat and muscle mass, blood circulation...).
Study NCT05148767 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Neoadjuvant chemoradiotherapy based on irinotecan
Description: Patients with locally advanced rectal cancer treated with irinotecan-based chemoradiotherapy were enrolled in this study. The dose of irinotecan is determined by the genotype of UGT1A1.Concurrent Chemoradiotherapy:~Radiation: 50Gy/25Fx; Capecitabine: 625mg/m2 bid Monday-Friday per week; Irinotecan: 80mg/m2 (UGT1A1\*28 and \*6: 6/6+GG) or 65mg/m2 (UGT1A1\*28 and \*6 ：6/7+GG or 6/6+GA) or 50mg/m2 （UGT1A1\*28 and \*6 ：7/7+GG or 6/6+AA or 6/7+GA）.
Study NCT06220266 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Phytoestrogen
Description: consume 1 capsule twice a day for 2 months which one capsule composed of dry weight 50 mg of Pueraria Mirifica 1or Pueraria Mirifica 2 or Pueraria Mirifica 3
Study NCT06220266 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Diet control & life style modification
Description: Diet control \& life style modification
Study NCT05126446 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: the Aorta Arch Stent Graft System combined with the Endovascular Needle System
Description: Patients who meet all the inclusion criteria and don't meet the exclusion criteria will be implanted with device
Study NCT06286787 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Intervention
Description: The training programme will consist of a 3-hour lecture. The contents of the lecture will include knowledge of mountaineering in Hong Kong, country codes and care for the environment, environmental awareness when undertaking outdoor activities, hiking skills, knowledge and choice of hiking equipment and clothing, trip planning, mountain safety, map reading, the use of a compass, mountain safety, basic first aid, methods of calling for help in an emergency and sources of weather data. After completing the lecture, participants will be required to join a 6-day hiking training programme on weekends within a 3-month period (each training will be at least 5 kilometres and the duration will be at least 4 hours).
Study NCT06286787 — intervention group
Intervention type: OTHER
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: Control participants will be asked to join six day-time leisure activities on weekends within a 3-month period. Leisure activities will be organised by the Asbury Methodist Social Service and will include cartoon film shows, handicraft workshops, chess games, health talks on the prevention of influenza and eating a healthy diet, and day visits to a museum and theme park. Children in the placebo control group will receive free access to leisure activities, including visits to museums and theme parks as an incentive for his/her participation.
Study NCT06378073 — intervention group
Intervention type: DIAGNOSTIC_TEST
Group type: EXPERIMENTAL
Intervention: Incentive Spirometer
Description: Specificity and sensitivity: Incentive spirometry is a specific type of spirometry that aims to encourage people to breathe deeply intentionally but does not provide a measurement or inform management of chronic lung diseases. Less than 5 repetitions per day (sensitivity 93%, specificity 77%) and less than 2 balls per repetition (sensitivity 93%, specificity 77%) were predictive of postoperative pulmonary complications. (1) Validity and reliability: Incentive spirometry can be used as a simple mean to follow lung function, especially VC, in the postoperative period in spontaneously breathing patients. Incentive spirometry is noninvasive and can be performed repeatedly at the bedside in the intensive care setting. (2)~Interpretation:~There are only three numeric values that are required to interpret spirometry:~* Forced Vital Capacity (FVC)~* Forced Expiratory Volume (FEV1)~* FEV1/FVC ratio.
Study NCT06378073 — intervention group
Intervention type: DIAGNOSTIC_TEST
Group type: OTHER
Intervention: Numeric Pain Rating Scale
Description: Sensitivity: The area under the receiver operator characteristic curve for the NRS as a test for pain that interferes with functioning was 0.76, indicating fair accuracy. A pain screening NRS score of 1 was 69% sensitive for pain that interferes with functioning. (4) he diagnostic value of different NRS cut-off values for administering analgesics is determined by an ROC curve. Sensitivity of NRS > 3 for 'unbearable' pain in older patients was 72% with a specificity of 97·2%. With a cut-off point NRS > 4, sensitivity increased to 83%, while specificity was 96·7%. (5) Validity and reliability: The numerical rating scale is a reliable and valid tool for pain assessment in patients with musculoskeletal impairments. (3)~Measurement (circle): Categorical /Numerical /Both:~Numerical:~The 11-point numeric scale ranges from '0' representing one pain extreme (e.g. no pain) to '10' representing the other pain extreme (e.g. pain as bad as you can imagine or worst pain imaginable)
Study NCT06549686 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: CLS2901C (human [allogeneic] chondrocyte sheets)
Description: CLS2901C (human \[allogeneic\] chondrocyte sheets)
Study NCT05904379 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: AK112
Description: Subjects receive AK112 intravenously.
Study NCT05904379 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: AK104
Description: Subjects receive AK104 intravenously.
Study NCT05904379 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Carboplatin
Description: Subjects receive carboplatin intravenously.
Study NCT04457271 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Goal Management Training (GMT)
Description: GMT is a structured, short-term cognitive remediation program with an emphasis on mindfulness and practice in planning and completion of goal-oriented behaviours. The main objective of GMT is to help participants regain executive control in order to better define goals and monitor performance in achieving them. Sessions include instructional material, interactive tasks, discussion of patients' real-life deficits, and homework assignments. Mindfulness meditation is also incorporated for the purpose of developing the skill of bringing one's mind to the present to monitor ongoing behaviour, goal states, and the relationship between them, and for the development of attentional control. The program incorporates real-life examples to illustrate goal attainment failures and successes, as well as in-session practice of complex tasks that mimic real-life tasks - typically a challenge for individuals with executive function deficits (e.g., planning and set-shifting tasks).
Study NCT05904379 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: paclitaxel
Description: Subjects receive paclitaxel intravenously.
Study NCT05904379 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: pemetrexed
Description: Subjects receive pemetrexed intravenously.
Study NCT05904379 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Docetaxel
Description: Subjects receive docetaxel intravenously.
Study NCT05904379 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Docetaxel
Description: Subjects receive docetaxel intravenously.
Study NCT06097988 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: ABIO3419
Description: Intra-articular injection
Study NCT04795453 — intervention group
Intervention type: OTHER
Intervention: score system to predict the need for surgery
Description: two and more grades of NEC is assessed using the score system to predict the need for surgery
Study NCT04795453 — intervention group
Intervention type: OTHER
Intervention: usual method to predict the need for surgery
Description: two and more grades of NEC is assessed using the usual method to predict the need for surgery
Study NCT05758441 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Mentoring to be Active plus Family
Description: Ten, structured peer mentoring sessions (once a week) covering new content each week and guided skill-building and practice. The MPBA sessions target increasing daily physical activity and replacing sugary drinks with water for hydration. Mentoring sessions are conducted virtually. A 6-month family reinforcement program follows with a reinforcement packet sent to child participants' homes once a month.
Study NCT06500689 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Allisartan Isoproxil/Sustained-Release Indapamide
Description: Double-blind period (Week 1\~Week 12): Allisartan Isoproxil/Sustained-Release Indapamide.~Open-label period (Week 13\~Week 52): Allisartan Isoproxil/Sustained-Release Indapamide.
Study NCT06500689 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Allisartan Isoproxil
Description: Double-blind period (Week 1\~Week 12): Allisartan Isoproxil.~Open-label period (Week 13\~Week 52): Allisartan Isoproxil/Sustained-Release Indapamide.
Study NCT05758441 — intervention group
Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Tracking Health and Fitness
Description: 10 self-guided, self-paced modules mailed to child participants home.
Study NCT06412055 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: NEURO SWING AFO (Fior& Gentz, Lüneburg In Duderstadt, Germany)
Description: stiffness-optimized custom-made spring-hinged AFO with the NEURO SWING® system ankle joint build in
Study NCT06412055 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: WalkOn Reaction® (Ottobock, Duderstadt)
Description: comparator: prefab spring-like AFO without hinge with a predefined stiffness (2.8 Nm/degree).
Study NCT06412055 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Matrix Max2® (TruLife, Dublin, Ireland)
Description: comparator: prefab spring-like AFO without hinge with a predefined stiffness (1.4 Nm/degree)
Study NCT06412055 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Matrix® (TruLife, Dublin, Ireland)
Description: comparator: prefab spring-like AFO without hinge with a predefined stiffness (0.6 Nm/degree)
Study NCT05980403 — intervention group
Intervention type: OTHER
Intervention: no intervention
Description: no intervention
Study NCT04534803 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: BCG Vaccine
Description: .1 mL of reconstituted BCG vaccine given intradermally at baseline.
Study NCT04534803 — intervention group
Intervention type: OTHER
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: .1 nL of diluent (saline) given intradermally at baseline
Study NCT06522503 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: stress ball
Description: The intervention group was provided with a stress ball to be held in both hands for a period of five minutes prior to the insertion of the port catheter needle. They were instructed to squeeze the ball in their hands at regular intervals until the conclusion of the procedure.
Study NCT06283589 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: INZ-701
Description: Recombinant fusion protein that contains the extracellular domains of human ENPP1 coupled with an Fc fragment from an immunoglobulin gamma-1 (IgG1) antibody.
Study NCT05470582 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: Flu-M, Inactivated split influenza vaccine 0.5 mL
Description: Solution for intramuscular injection Сhildren were vaccinated with the Flu-M vaccine once/twice (all children were vaccinated twice with an interval of 28 days between the first vaccination and revaccination; if the child is vaccinated for the first time) intramuscularly in a dose of 0.5 mL
Study NCT05470582 — intervention group
Intervention type: BIOLOGICAL
Group type: ACTIVE_COMPARATOR
Intervention: Vaxigrip, Inactivated split influenza vaccine 0.5 mL
Description: Suspension for intramuscular and subcutaneous injection Children were vaccinated with the Vaxigrip® vaccine once/twice (all children were vaccinated twice with an interval of 28 days between the first vaccination and revaccination; if the child is vaccinated for the first time) intramuscularly in a dose of 0.5 mL
Study NCT05470582 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: Flu-M, Inactivated split influenza vaccine 0.25 mL
Description: Solution for intramuscular injection Children were vaccinated with the Flu-M vaccine twice (all children were vaccinated twice with an interval of 28 days between the first vaccination and revaccination) intramuscularly in a dose of 0.25 mL
Study NCT05470582 — intervention group
Intervention type: BIOLOGICAL
Group type: ACTIVE_COMPARATOR
Intervention: Vaxigrip, Inactivated split influenza vaccine 0.25 mL
Description: Suspension for intramuscular and subcutaneous injection Children were vaccinated with the Vaxigrip® vaccine twice (all children were vaccinated twice with an interval of 28 days between the first vaccination and revaccination) intramuscularly in a dose of 0.25 mL
Study NCT04539301 — intervention group
Intervention type: DIAGNOSTIC_TEST
Intervention: Estimated anticoagulant level (conversion factor x anti-Xa activity)
Description: Estimated anticoagulant level (conversion factor x anti-Xa activity)
Study NCT06078176 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Electrical Rectal Stimulation
Description: Electrical stimulation of the rectum will be applied to activate sensory afferent neurons of the rectum and evoke a recto-colonic reflex to improve colonic motility and facilitate bowel emptying. This intervention will compared to individuals' usual mechanical intervention of digital rectal stimulation.
Study NCT05659316 — intervention group
Intervention type: OTHER
Intervention: MRI imaging
Description: Knee MRI imaging
Study NCT06678711 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: minimal invasive surgery-posterior atlantoaxial lateral mass joint fusion
Description: Make a 4.5 cm incision along the median line and then dissect the trapezius, splenius capitis, and semispinalis capitis muscle laterally 1.5 cm off the median line. Retract the obliquus capitis inferior muscle to expose the C1-C2 intra-articular space. Remove the articular cartilage, insert allogenic granular bone and 3D-printed cage. Place the screws and rod in the same positions as conventional surgery, and the operation is completed.
Study NCT06678711 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Open atlantoaxial fixation and fusion
Description: The Goel-Harms procedure will be used in the control group. Screws and rods are placed in the same position as in the experimental group, and a negative-pressure drain was placed until daily drainage was \<50 mL.